DWT
MRNA icon

Dorsey & Whitney Trust’s Moderna MRNA Stock Holding History

Dorsey & Whitney Trust’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,946
Closed -$200K – 757
2026
Q1 		$200K Buy
+3,946
New +$184K 0.01% 691
2024
Q4 		– Sell
-6,019
Closed -$402K – 697
2024
Q3 		$402K Sell
6,019
-1,176
-16% -$108K 0.02% 439
2024
Q2 		$854K Buy
7,195
+104
+1% +$13.2K 0.06% 242
2024
Q1 		$756K Buy
7,091
+4,628
+188% +$466K 0.05% 262
2023
Q4 		$245K Sell
2,463
-2,669
-52% -$224K 0.02% 515
2023
Q3 		$530K Sell
5,132
-549
-10% -$61.2K 0.05% 307
2023
Q2 		$690K Buy
5,681
+2,212
+64% +$295K 0.06% 257
2023
Q1 		$533K Buy
+3,469
New +$572K 0.05% 300

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Dorsey & Whitney Trust's MRNA Position: Q2 2026 in Review

Dorsey & Whitney Trust sold out of Moderna (MRNA) in Q2 2026, closing a stake of 3,946 shares — an estimated $200K sold.

Dorsey & Whitney Trust first reported a position in MRNA in Q1 2023 and held it in 8 quarters. The position peaked at $854K in Q2 2024. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Dorsey & Whitney Trust reported no remaining Moderna position as of Q2 2026 after selling out during the quarter.
  • Dorsey & Whitney Trust sold 3,946 Moderna shares in Q2 2026, an estimated $200K.
  • Dorsey & Whitney Trust first reported a position in Moderna in Q1 2023 and held it in 8 quarters.
  • Dorsey & Whitney Trust's Moderna position peaked at $854K in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.